Semaglutide TFA, the trifluoroacetic acid salt form of Semaglutide. Semaglutide acts like human glucagon-like peptide-1 (GLP-1) such that it increases insulin secretion, thereby increasing sugar metabolism. Semaglutide, sold under the brand name Ozempic among others, is an anti-diabetic medicationused for the treatment of type 2 diabetes and chronic weight management.
Order information
Description
Product Name | Semaglutide TFA |
Brand name | Ozempic |
CAS No. | 910463-68-2 |
Formula | C189H292F3N45O61 |
Biological Activity | Semaglutide acts like human glucagon-like peptide-1 (GLP-1) such that it increases insulin secretion. |
Purity | Purity: ≥98% (HPLC) |
Application | Therapeutic peptides drug benchmark or raw material for peptide drugs or peptide conjugation drugs discovery and development. |
Predicted Molecular Mass | 4210.63 |
Formulation | Powder |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |